SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
Valeant Stock Falls on Default Fears, U.S. Rep. Criticizes Company Over Philidor
April 12, 2016
 · 
3 min read
Deals
Allergan Chief Brent Saunders On Failed Pfizer Deal And Why He’s Not Like Valeant
April 8, 2016
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant’s Ackman Says Company Will Not Sell Bausch & Lomb
April 8, 2016
 · 
3 min read
Business
Ackman Says New Valeant CEO Will be Named Within Weeks
April 7, 2016
 · 
3 min read
Job Trends
Sprout Team Withers as Valeant Terminates 140 Sales Contractors for the Female Libido Drug
April 5, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
As Flailing Valeant Pushes Back Earnings Deadlines, Bausch & Lomb Sale Potentially on the Table
March 30, 2016
 · 
3 min read
FDA Wades Into Drug Pricing
Policy
FDA’s Big Task: Stop The Next Martin Shkreli and Valeant
March 28, 2016
 · 
4 min read
Business
How Pearson Should Manage His Remaining Time As CEO Of Valeant
March 23, 2016
 · 
1 min read
Former Valeant CEO Nabs $9+ Million Severance Deal and Consulting Role
Business
Valeant Hunts for a New CEO, Blames Former CFO Schiller for Recent Financial Misstatements
March 21, 2016
 · 
3 min read
Load More
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
 · 
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
 · 
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
 · 
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
 · 
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
 · 
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
 · 
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
 · 
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
 · 
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
 · 
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
 · 
4 min read
Load More